A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
Recap by typeshit. Full story at Philstar Life.
She points out one trial enrolled people with diabetes and the other excluded them, so the results aren't a head to head match.
Researchers built a topology-guided add-on to AlphaFold3 aimed at the threaded tail that trips up lasso peptide structure prediction.
Gannan Medical University researchers screened 6,000 candidates from Hypsizygus marmoreus and found peptides that may help cut sodium without losing flavor.
8:28
A weight loss doctor walks through retatrutide, which she calls the most anticipated obesity drug currently in clinical trials.
One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Loading…